Plasma platelet-activating factor acetylhydrolase deficiency is associated with atherosclerotic occlusive disease in Japan
- 1 August 2000
- journal article
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 32 (2) , 263-267
- https://doi.org/10.1067/mva.2000.105670
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- What Effect Does Controlling Platelets Have on Atherosclerosis?Annals of the New York Academy of Sciences, 2006
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Depressed Plasma Platelet- Activating Factor Acetylhydrolasein Pat ients Presenting with Acute Myocardial InfarctionCardiology, 1998
- Identification of the G994 → T missense mutation in exon 9 of the plasma platelet-activating factor acetylhydrolase gene as an independent risk factor for coronary artery disease in Japanese menMetabolism, 1998
- A Mutation in Plasma Platelet-Activating Factor Acetylhydrolase (Val 279 →Phe) is a Genetic Risk Factor for StrokeStroke, 1997
- Loss of Activity of Plasma Platelet-Activating Factor Acetylhydrolase Due to a Novel Gln281→Arg MutationBiochemical and Biophysical Research Communications, 1997
- Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase.Journal of Clinical Investigation, 1996
- Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein.Journal of Clinical Investigation, 1995
- Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarctionNature, 1992
- Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children.Journal of Clinical Investigation, 1988